The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

Shares of Merck KGaA surged after the company confirmed its outlook for fiscal year 2024 and revisions to its mid-term sales ...

Merck KGaA said its doors are open for more M&A, particularly for its manufacturing business, as the company tempers sales ...

This is the second SOD application center that Merck has established in Asia to meet the region’s high demand.

German stocks traded higher on Thursday as investors digested a slew of earnings and awaited an interest rate cut by the European ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has recently opened its new ...

Deutsche Bank (ETR:DBKGn) has adjusted its price target for Merck KGaA (MRK: GR) (OTC: MKGAF), reducing it to €180.00 from the previous €188.00, while retaining a Buy rating on the stock. The ...

Deutsche Bank has adjusted its price target for Merck KGaA (MRK: GR) (OTC: MKGAF), reducing it to €180.00 from the previous €188.00, while retaining a Buy rating on the stock. The modification ...

When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...

Germany stocks were higher after the close on Thursday, as gains in the Pharmaceuticals & Healthcare, Industrials and ...